Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


C4XD Names New Chair

This article was originally published in Scrip

Executive Summary

C4X Discovery Holdings plc, a drug discovery and design company, has appointed Dr. Clive Dix executive chair. Dix was previously non-executive chair of C4XD's board of directors; now as executive chair he will build upon the strong achievements C4XD has made to date in fulfilling its ambition to become "one of the world's leading hubs for the discovery of novel drugs against critical therapeutic targets." Recent achievements include advances in its Orexin-1, IL-17, GPR142 and NRF-2 programs and the signing of a collaboration with the Structural Genomics Consortium at Oxford University.




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts